13F reference period
Q2 2026
Security Snapshot
Valion Bio, Inc. - Common Stock (VBIO) Institutional Ownership
CUSIP: 888705308
13F Institutional Holders and Ownership History from Q1 2025 to Q3 2026
Institutions Reporting
13
Shares (Excl. Options)
398.07K
Full value: 398,071 · shares · 30 Jun 2026Price
$0.52
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- VBIO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 398,071
- Total 13F value
- $205,604
- Portfolio coverage rank
- 0%
- Share change
- +133,893
- Value change
- +$67,970
- Number of holders
- 13
- Shares outstanding
- 33,678,172
- SEC-reported price per share
- $0.16
- Insider filing price
- $0.16
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- VBIO - Valion Bio, Inc. - Common Stock is tracked under CUSIP 888705308.
- 13 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 9 to 13 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$233.43K
Full value: $233,432 · USD · 31 Mar 2026.$205.6K
Full value: $205,604 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 13 institutions filings for Q2 2026.
Security key
888705308
13F reference period
Q2 2026
13F holders
13
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
VBIO full holder history
Valion Bio, Inc. SEC filings
Valion Bio, Inc. company facts
Valion Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 888705308:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
VBIO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 3i, LP | 9.9% | 0% | $933,559 | +$344,781 | 3,334,139 | +59% | 3i, LP | 25 Aug 2026 |
| Murchinson Ltd. | 10% | $242,133 | 440,242 | Murchinson Ltd. | 08 Jun 2026 |
As of 30 Jun 2026,
13
institutional investors reported holding
shares of
Valion Bio, Inc. - Common Stock (VBIO).
This represents
1.2%
of the company’s total
outstanding shares.
398.07K
Full value: 398,071 · shares · 30 Jun 202633.68M
Full value: 33,678,172 · shares · Stored outstanding share countQuarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Headline period
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 0 | $0 | -$10 | $0.16 | 0 |
| 2026 Q2 | 398,071 | $205,604 | +$67,970 | $0.52 | 13 |
| 2026 Q1 | 264,178 | $233,432 | +$149,784 | $0.89 | 9 |
| 2025 Q4 | 81,915 | $118,778 | -$96,033 | $1.45 | 7 |
| 2025 Q3 | 196,221 | $567,079 | +$437,141 | $2.89 | 7 |
| 2025 Q2 | 44,961 | $186,587 | +$23,476 | $4.14 | 4 |
| 2025 Q1 | 21 | $54 | +$54 | $2.58 | 2 |